CA3211663A1 - Systeme electronique de surveillance de la conformite de la medication et methodes associees - Google Patents

Systeme electronique de surveillance de la conformite de la medication et methodes associees

Info

Publication number: CA3211663A1
Authority: CA; Canada
Prior art keywords: tag; patient; electronic; reader; link
Prior art date: 2015-10-13
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Pending

Application number

CA3211663A

Other languages

English (en)

Inventor

Neil R. Euliano Ii

Brent A. Myers

Jose C. Principe

Venkata V. Meka

Glen FLORES

Shalom Darmanijan

Eric Buffkin

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Etectrx Inc

Original Assignee

Etectrx Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2015-10-13

Filing date

2015-10-13

Publication date

2017-04-13

2015-10-13 Application filed by Etectrx Inc filed Critical Etectrx Inc

2015-10-13 Priority to CA3211663A priority Critical patent/CA3211663A1/fr

2017-04-13 Publication of CA3211663A1 publication Critical patent/CA3211663A1/fr

Status Pending legal-status Critical Current

Links

229940079593 drug Drugs 0.000 title claims abstract description 144
239000003814 drug Substances 0.000 title claims abstract description 142
238000000034 method Methods 0.000 title claims abstract description 62
238000012544 monitoring process Methods 0.000 title claims abstract description 50
239000002775 capsule Substances 0.000 claims abstract description 91
230000005540 biological transmission Effects 0.000 claims description 61
239000000758 substrate Substances 0.000 claims description 51
230000002496 gastric effect Effects 0.000 claims description 35
238000000576 coating method Methods 0.000 claims description 31
230000037406 food intake Effects 0.000 claims description 25
239000012530 fluid Substances 0.000 claims description 24
238000003306 harvesting Methods 0.000 claims description 24
238000001514 detection method Methods 0.000 claims description 22
239000002184 metal Substances 0.000 claims description 20
229910052751 metal Inorganic materials 0.000 claims description 20
210000001035 gastrointestinal tract Anatomy 0.000 claims description 17
239000011248 coating agent Substances 0.000 claims description 15
230000004913 activation Effects 0.000 claims description 14
BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 claims description 13
238000005259 measurement Methods 0.000 claims description 13
238000012545 processing Methods 0.000 claims description 12
HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims description 11
150000001875 compounds Chemical class 0.000 claims description 11
229910052709 silver Inorganic materials 0.000 claims description 11
239000004332 silver Substances 0.000 claims description 11
229910052725 zinc Inorganic materials 0.000 claims description 10
239000011701 zinc Substances 0.000 claims description 10
238000000513 principal component analysis Methods 0.000 claims description 7
238000006243 chemical reaction Methods 0.000 claims description 6
239000007788 liquid Substances 0.000 claims description 6
231100000252 nontoxic Toxicity 0.000 claims description 6
230000003000 nontoxic effect Effects 0.000 claims description 6
FJOLTQXXWSRAIX-UHFFFAOYSA-K silver phosphate Chemical compound [Ag+].[Ag+].[Ag+].[O-]P([O-])([O-])=O FJOLTQXXWSRAIX-UHFFFAOYSA-K 0.000 claims description 6
229940019931 silver phosphate Drugs 0.000 claims description 6
229910000161 silver phosphate Inorganic materials 0.000 claims description 6
OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 5
229910052799 carbon Inorganic materials 0.000 claims description 5
230000001360 synchronised effect Effects 0.000 claims description 5
230000003213 activating effect Effects 0.000 claims 1
230000001419 dependent effect Effects 0.000 claims 1
239000006187 pill Substances 0.000 description 82
238000004891 communication Methods 0.000 description 50
239000000463 material Substances 0.000 description 26
210000002784 stomach Anatomy 0.000 description 21
239000000126 substance Substances 0.000 description 21
210000004027 cell Anatomy 0.000 description 20
239000010410 layer Substances 0.000 description 13
230000008569 process Effects 0.000 description 13
239000003990 capacitor Substances 0.000 description 12
238000010586 diagram Methods 0.000 description 12
239000000243 solution Substances 0.000 description 11
238000013459 approach Methods 0.000 description 10
230000008859 change Effects 0.000 description 10
238000013461 design Methods 0.000 description 10
230000033001 locomotion Effects 0.000 description 10
238000004519 manufacturing process Methods 0.000 description 10
238000002483 medication Methods 0.000 description 10
230000008901 benefit Effects 0.000 description 9
239000002702 enteric coating Substances 0.000 description 8
238000009505 enteric coating Methods 0.000 description 8
210000003238 esophagus Anatomy 0.000 description 8
239000000976 ink Substances 0.000 description 8
239000000203 mixture Substances 0.000 description 8
238000007639 printing Methods 0.000 description 8
210000001124 body fluid Anatomy 0.000 description 7
238000010276 construction Methods 0.000 description 7
230000007246 mechanism Effects 0.000 description 7
150000002739 metals Chemical class 0.000 description 7
230000011664 signaling Effects 0.000 description 7
230000015556 catabolic process Effects 0.000 description 6
239000004020 conductor Substances 0.000 description 6
230000000694 effects Effects 0.000 description 6
238000001727 in vivo Methods 0.000 description 6
239000000523 sample Substances 0.000 description 6
102000009027 Albumins Human genes 0.000 description 5
108010088751 Albumins Proteins 0.000 description 5
239000000853 adhesive Substances 0.000 description 5
230000001070 adhesive effect Effects 0.000 description 5
238000006731 degradation reaction Methods 0.000 description 5
239000003989 dielectric material Substances 0.000 description 5
238000004090 dissolution Methods 0.000 description 5
239000007903 gelatin capsule Substances 0.000 description 5
239000000017 hydrogel Substances 0.000 description 5
239000002245 particle Substances 0.000 description 5
239000011253 protective coating Substances 0.000 description 5
102000004169 proteins and genes Human genes 0.000 description 5
108090000623 proteins and genes Proteins 0.000 description 5
238000003860 storage Methods 0.000 description 5
210000001519 tissue Anatomy 0.000 description 5
239000013598 vector Substances 0.000 description 5
208000030453 Drug-Related Side Effects and Adverse reaction Diseases 0.000 description 4
229920003134 Eudragit® polymer Polymers 0.000 description 4
XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 4
VVQNEPGJFQJSBK-UHFFFAOYSA-N Methyl methacrylate Chemical compound COC(=O)C(C)=C VVQNEPGJFQJSBK-UHFFFAOYSA-N 0.000 description 4
239000002253 acid Substances 0.000 description 4
238000004458 analytical method Methods 0.000 description 4
230000029087 digestion Effects 0.000 description 4
230000036541 health Effects 0.000 description 4
230000000737 periodic effect Effects 0.000 description 4
230000004044 response Effects 0.000 description 4
230000009466 transformation Effects 0.000 description 4
229920000623 Cellulose acetate phthalate Polymers 0.000 description 3
RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 3
102000004190 Enzymes Human genes 0.000 description 3
108090000790 Enzymes Proteins 0.000 description 3
229910021607 Silver chloride Inorganic materials 0.000 description 3
230000009286 beneficial effect Effects 0.000 description 3
210000004369 blood Anatomy 0.000 description 3
239000008280 blood Substances 0.000 description 3
229940081734 cellulose acetate phthalate Drugs 0.000 description 3
230000001427 coherent effect Effects 0.000 description 3
210000001072 colon Anatomy 0.000 description 3
229910052802 copper Inorganic materials 0.000 description 3
239000010949 copper Substances 0.000 description 3
239000013078 crystal Substances 0.000 description 3
230000009849 deactivation Effects 0.000 description 3
102000038379 digestive enzymes Human genes 0.000 description 3
108091007734 digestive enzymes Proteins 0.000 description 3
238000005516 engineering process Methods 0.000 description 3
229940088598 enzyme Drugs 0.000 description 3
239000000284 extract Substances 0.000 description 3
238000001465 metallisation Methods 0.000 description 3
238000012806 monitoring device Methods 0.000 description 3
230000003285 pharmacodynamic effect Effects 0.000 description 3
230000001681 protective effect Effects 0.000 description 3
230000002829 reductive effect Effects 0.000 description 3
238000000926 separation method Methods 0.000 description 3
HKZLPVFGJNLROG-UHFFFAOYSA-M silver monochloride Chemical compound [Cl-].[Ag+] HKZLPVFGJNLROG-UHFFFAOYSA-M 0.000 description 3
235000000346 sugar Nutrition 0.000 description 3
238000012360 testing method Methods 0.000 description 3
230000007704 transition Effects 0.000 description 3
ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 2
208000035473 Communicable disease Diseases 0.000 description 2
AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 2
239000007836 KH2PO4 Substances 0.000 description 2
229910019142 PO4 Inorganic materials 0.000 description 2
102000057297 Pepsin A Human genes 0.000 description 2
108090000284 Pepsin A Proteins 0.000 description 2
229920000954 Polyglycolide Polymers 0.000 description 2
XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 2
QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
150000007513 acids Chemical class 0.000 description 2
230000003321 amplification Effects 0.000 description 2
239000010405 anode material Substances 0.000 description 2
239000000560 biocompatible material Substances 0.000 description 2
239000000090 biomarker Substances 0.000 description 2
230000036765 blood level Effects 0.000 description 2
239000010839 body fluid Substances 0.000 description 2
239000006229 carbon black Substances 0.000 description 2
239000010406 cathode material Substances 0.000 description 2
230000001413 cellular effect Effects 0.000 description 2
239000003795 chemical substances by application Substances 0.000 description 2
239000000460 chlorine Substances 0.000 description 2
229910052801 chlorine Inorganic materials 0.000 description 2
230000008867 communication pathway Effects 0.000 description 2
230000001079 digestive effect Effects 0.000 description 2
238000002651 drug therapy Methods 0.000 description 2
230000009977 dual effect Effects 0.000 description 2
210000001198 duodenum Anatomy 0.000 description 2
238000009713 electroplating Methods 0.000 description 2
239000011888 foil Substances 0.000 description 2
230000006870 function Effects 0.000 description 2
235000021472 generally recognized as safe Nutrition 0.000 description 2
239000005556 hormone Substances 0.000 description 2
229940088597 hormone Drugs 0.000 description 2
238000007654 immersion Methods 0.000 description 2
230000010354 integration Effects 0.000 description 2
230000003993 interaction Effects 0.000 description 2
210000000936 intestine Anatomy 0.000 description 2
229910052742 iron Inorganic materials 0.000 description 2
230000000670 limiting effect Effects 0.000 description 2
239000011159 matrix material Substances 0.000 description 2
229910000402 monopotassium phosphate Inorganic materials 0.000 description 2
235000019796 monopotassium phosphate Nutrition 0.000 description 2
210000003205 muscle Anatomy 0.000 description 2
238000003199 nucleic acid amplification method Methods 0.000 description 2
230000003287 optical effect Effects 0.000 description 2
229940111202 pepsin Drugs 0.000 description 2
238000005325 percolation Methods 0.000 description 2
230000002572 peristaltic effect Effects 0.000 description 2
NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 2
239000010452 phosphate Substances 0.000 description 2
239000004633 polyglycolic acid Substances 0.000 description 2
229950008885 polyglycolic acid Drugs 0.000 description 2
229920001343 polytetrafluoroethylene Polymers 0.000 description 2
239000004810 polytetrafluoroethylene Substances 0.000 description 2
GNSKLFRGEWLPPA-UHFFFAOYSA-M potassium dihydrogen phosphate Chemical compound [K+].OP(O)([O-])=O GNSKLFRGEWLPPA-UHFFFAOYSA-M 0.000 description 2
230000002265 prevention Effects 0.000 description 2
239000000047 product Substances 0.000 description 2
230000000644 propagated effect Effects 0.000 description 2
230000001105 regulatory effect Effects 0.000 description 2
239000004065 semiconductor Substances 0.000 description 2
230000035945 sensitivity Effects 0.000 description 2
229910052710 silicon Inorganic materials 0.000 description 2
239000010703 silicon Substances 0.000 description 2
238000011524 similarity measure Methods 0.000 description 2
230000008961 swelling Effects 0.000 description 2
230000000007 visual effect Effects 0.000 description 2
210000000707 wrist Anatomy 0.000 description 2
ZXSQEZNORDWBGZ-UHFFFAOYSA-N 1,3-dihydropyrrolo[2,3-b]pyridin-2-one Chemical compound C1=CN=C2NC(=O)CC2=C1 ZXSQEZNORDWBGZ-UHFFFAOYSA-N 0.000 description 1
206010061623 Adverse drug reaction Diseases 0.000 description 1
BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 1
241000894006 Bacteria Species 0.000 description 1
208000017667 Chronic Disease Diseases 0.000 description 1
206010012335 Dependence Diseases 0.000 description 1
241000196324 Embryophyta Species 0.000 description 1
239000004593 Epoxy Substances 0.000 description 1
ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 1
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
241000282412 Homo Species 0.000 description 1
240000007594 Oryza sativa Species 0.000 description 1
235000007164 Oryza sativa Nutrition 0.000 description 1
239000004642 Polyimide Substances 0.000 description 1
BSJXPETYZVMWHM-UHFFFAOYSA-L S(=O)(=O)([O-])[O-].[Zn+2].[Ag+] Chemical compound S(=O)(=O)([O-])[O-].[Zn+2].[Ag+] BSJXPETYZVMWHM-UHFFFAOYSA-L 0.000 description 1
229920002472 Starch Polymers 0.000 description 1
JJWCNLOSXJMLAP-UHFFFAOYSA-K [Ag+].P(=O)([O-])([O-])[O-].[Cu+2] Chemical compound [Ag+].P(=O)([O-])([O-])[O-].[Cu+2] JJWCNLOSXJMLAP-UHFFFAOYSA-K 0.000 description 1
MQIGIUNAEDOSKG-UHFFFAOYSA-K [Zn+2].[Ag+].[O-]P([O-])([O-])=O Chemical compound [Zn+2].[Ag+].[O-]P([O-])([O-])=O MQIGIUNAEDOSKG-UHFFFAOYSA-K 0.000 description 1
238000010521 absorption reaction Methods 0.000 description 1
229960001138 acetylsalicylic acid Drugs 0.000 description 1
230000002378 acidificating effect Effects 0.000 description 1
230000001464 adherent effect Effects 0.000 description 1
238000004026 adhesive bonding Methods 0.000 description 1
230000002411 adverse Effects 0.000 description 1
150000001450 anions Chemical class 0.000 description 1
QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
230000002238 attenuated effect Effects 0.000 description 1
230000006399 behavior Effects 0.000 description 1
239000002876 beta blocker Substances 0.000 description 1
229940097320 beta blocking agent Drugs 0.000 description 1
230000002457 bidirectional effect Effects 0.000 description 1
238000006065 biodegradation reaction Methods 0.000 description 1
210000000601 blood cell Anatomy 0.000 description 1
230000017531 blood circulation Effects 0.000 description 1
238000010241 blood sampling Methods 0.000 description 1
230000036760 body temperature Effects 0.000 description 1
210000000988 bone and bone Anatomy 0.000 description 1
238000006555 catalytic reaction Methods 0.000 description 1
229940121657 clinical drug Drugs 0.000 description 1
239000012612 commercial material Substances 0.000 description 1
239000002322 conducting polymer Substances 0.000 description 1
229920001940 conductive polymer Polymers 0.000 description 1
238000012790 confirmation Methods 0.000 description 1
229920001577 copolymer Polymers 0.000 description 1
230000002089 crippling effect Effects 0.000 description 1
238000013075 data extraction Methods 0.000 description 1
238000013500 data storage Methods 0.000 description 1
230000003247 decreasing effect Effects 0.000 description 1
230000000593 degrading effect Effects 0.000 description 1
230000003111 delayed effect Effects 0.000 description 1
238000011161 development Methods 0.000 description 1
206010012601 diabetes mellitus Diseases 0.000 description 1
235000005911 diet Nutrition 0.000 description 1
230000037213 diet Effects 0.000 description 1
235000015872 dietary supplement Nutrition 0.000 description 1
238000009792 diffusion process Methods 0.000 description 1
210000002249 digestive system Anatomy 0.000 description 1
201000010099 disease Diseases 0.000 description 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
231100000673 dose–response relationship Toxicity 0.000 description 1
238000009509 drug development Methods 0.000 description 1
238000000866 electrolytic etching Methods 0.000 description 1
230000005672 electromagnetic field Effects 0.000 description 1
238000004146 energy storage Methods 0.000 description 1
230000007613 environmental effect Effects 0.000 description 1
238000005530 etching Methods 0.000 description 1
230000005284 excitation Effects 0.000 description 1
230000029142 excretion Effects 0.000 description 1
238000000605 extraction Methods 0.000 description 1
230000001605 fetal effect Effects 0.000 description 1
239000000835 fiber Substances 0.000 description 1
210000004051 gastric juice Anatomy 0.000 description 1
210000003736 gastrointestinal content Anatomy 0.000 description 1
210000005095 gastrointestinal system Anatomy 0.000 description 1
239000007897 gelcap Substances 0.000 description 1
239000008103 glucose Substances 0.000 description 1
PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
229910052737 gold Inorganic materials 0.000 description 1
239000010931 gold Substances 0.000 description 1
238000005470 impregnation Methods 0.000 description 1
230000006872 improvement Effects 0.000 description 1
230000006698 induction Effects 0.000 description 1
150000002500 ions Chemical class 0.000 description 1
238000002955 isolation Methods 0.000 description 1
238000002032 lab-on-a-chip Methods 0.000 description 1
238000001459 lithography Methods 0.000 description 1
238000011068 loading method Methods 0.000 description 1
230000005389 magnetism Effects 0.000 description 1
239000003550 marker Substances 0.000 description 1
230000004630 mental health Effects 0.000 description 1
239000007769 metal material Substances 0.000 description 1
230000003278 mimic effect Effects 0.000 description 1
239000011259 mixed solution Substances 0.000 description 1
238000012986 modification Methods 0.000 description 1
230000004048 modification Effects 0.000 description 1
208000010125 myocardial infarction Diseases 0.000 description 1
239000002105 nanoparticle Substances 0.000 description 1
239000002547 new drug Substances 0.000 description 1
230000000474 nursing effect Effects 0.000 description 1
235000016709 nutrition Nutrition 0.000 description 1
230000035764 nutrition Effects 0.000 description 1
239000003921 oil Substances 0.000 description 1
239000011368 organic material Substances 0.000 description 1
229910052760 oxygen Inorganic materials 0.000 description 1
239000001301 oxygen Substances 0.000 description 1
238000004806 packaging method and process Methods 0.000 description 1
230000036961 partial effect Effects 0.000 description 1
239000012466 permeate Substances 0.000 description 1
229940068196 placebo Drugs 0.000 description 1
239000000902 placebo Substances 0.000 description 1
230000010287 polarization Effects 0.000 description 1
229920000747 poly(lactic acid) Polymers 0.000 description 1
229920003229 poly(methyl methacrylate) Polymers 0.000 description 1
229920001721 polyimide Polymers 0.000 description 1
239000004626 polylactic acid Substances 0.000 description 1
229920000642 polymer Polymers 0.000 description 1
239000004926 polymethyl methacrylate Substances 0.000 description 1
-1 polytetrafluoroethylene Polymers 0.000 description 1
238000010248 power generation Methods 0.000 description 1
239000002243 precursor Substances 0.000 description 1
230000002250 progressing effect Effects 0.000 description 1
239000011241 protective layer Substances 0.000 description 1
238000013138 pruning Methods 0.000 description 1
230000000541 pulsatile effect Effects 0.000 description 1
238000002106 pulse oximetry Methods 0.000 description 1
230000005855 radiation Effects 0.000 description 1
210000000664 rectum Anatomy 0.000 description 1
238000012552 review Methods 0.000 description 1
235000009566 rice Nutrition 0.000 description 1
210000003296 saliva Anatomy 0.000 description 1
238000005070 sampling Methods 0.000 description 1
229910001958 silver carbonate Inorganic materials 0.000 description 1
LKZMBDSASOBTPN-UHFFFAOYSA-L silver carbonate Substances [Ag].[O-]C([O-])=O LKZMBDSASOBTPN-UHFFFAOYSA-L 0.000 description 1
229940100890 silver compound Drugs 0.000 description 1
150000003379 silver compounds Chemical class 0.000 description 1
YPNVIBVEFVRZPJ-UHFFFAOYSA-L silver sulfate Chemical compound [Ag+].[Ag+].[O-]S([O-])(=O)=O YPNVIBVEFVRZPJ-UHFFFAOYSA-L 0.000 description 1
229910000367 silver sulfate Inorganic materials 0.000 description 1
238000005245 sintering Methods 0.000 description 1
210000000813 small intestine Anatomy 0.000 description 1
235000014214 soft drink Nutrition 0.000 description 1
239000007787 solid Substances 0.000 description 1
239000011343 solid material Substances 0.000 description 1
239000008107 starch Substances 0.000 description 1
235000019698 starch Nutrition 0.000 description 1
230000001954 sterilising effect Effects 0.000 description 1
238000004659 sterilization and disinfection Methods 0.000 description 1
150000008163 sugars Chemical class 0.000 description 1
239000013589 supplement Substances 0.000 description 1
230000000153 supplemental effect Effects 0.000 description 1
230000008685 targeting Effects 0.000 description 1
238000012549 training Methods 0.000 description 1
238000012546 transfer Methods 0.000 description 1
238000000844 transformation Methods 0.000 description 1
230000001960 triggered effect Effects 0.000 description 1
238000009966 trimming Methods 0.000 description 1
210000002700 urine Anatomy 0.000 description 1
239000001993 wax Substances 0.000 description 1
230000003442 weekly effect Effects 0.000 description 1
238000009736 wetting Methods 0.000 description 1
150000003752 zinc compounds Chemical class 0.000 description 1

Classifications

- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06K—GRAPHICAL DATA READING; PRESENTATION OF DATA; RECORD CARRIERS; HANDLING RECORD CARRIERS
- G06K19/00—Record carriers for use with machines and with at least a part designed to carry digital markings
- G06K19/06—Record carriers for use with machines and with at least a part designed to carry digital markings characterised by the kind of the digital marking, e.g. shape, nature, code
- G06K19/067—Record carriers with conductive marks, printed circuits or semiconductor circuit elements, e.g. credit or identity cards also with resonating or responding marks without active components
- G06K19/07—Record carriers with conductive marks, printed circuits or semiconductor circuit elements, e.g. credit or identity cards also with resonating or responding marks without active components with integrated circuit chips
- G06K19/077—Constructional details, e.g. mounting of circuits in the carrier
- G06K19/07745—Mounting details of integrated circuit chips
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06K—GRAPHICAL DATA READING; PRESENTATION OF DATA; RECORD CARRIERS; HANDLING RECORD CARRIERS
- G06K19/00—Record carriers for use with machines and with at least a part designed to carry digital markings
- G06K19/06—Record carriers for use with machines and with at least a part designed to carry digital markings characterised by the kind of the digital marking, e.g. shape, nature, code
- G06K19/067—Record carriers with conductive marks, printed circuits or semiconductor circuit elements, e.g. credit or identity cards also with resonating or responding marks without active components
- G06K19/07—Record carriers with conductive marks, printed circuits or semiconductor circuit elements, e.g. credit or identity cards also with resonating or responding marks without active components with integrated circuit chips
- G06K19/0716—Record carriers with conductive marks, printed circuits or semiconductor circuit elements, e.g. credit or identity cards also with resonating or responding marks without active components with integrated circuit chips at least one of the integrated circuit chips comprising a sensor or an interface to a sensor
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06K—GRAPHICAL DATA READING; PRESENTATION OF DATA; RECORD CARRIERS; HANDLING RECORD CARRIERS
- G06K19/00—Record carriers for use with machines and with at least a part designed to carry digital markings
- G06K19/06—Record carriers for use with machines and with at least a part designed to carry digital markings characterised by the kind of the digital marking, e.g. shape, nature, code
- G06K19/067—Record carriers with conductive marks, printed circuits or semiconductor circuit elements, e.g. credit or identity cards also with resonating or responding marks without active components
- G06K19/07—Record carriers with conductive marks, printed circuits or semiconductor circuit elements, e.g. credit or identity cards also with resonating or responding marks without active components with integrated circuit chips
- G06K19/0723—Record carriers with conductive marks, printed circuits or semiconductor circuit elements, e.g. credit or identity cards also with resonating or responding marks without active components with integrated circuit chips the record carrier comprising an arrangement for non-contact communication, e.g. wireless communication circuits on transponder cards, non-contact smart cards or RFIDs
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06K—GRAPHICAL DATA READING; PRESENTATION OF DATA; RECORD CARRIERS; HANDLING RECORD CARRIERS
- G06K19/00—Record carriers for use with machines and with at least a part designed to carry digital markings
- G06K19/06—Record carriers for use with machines and with at least a part designed to carry digital markings characterised by the kind of the digital marking, e.g. shape, nature, code
- G06K19/067—Record carriers with conductive marks, printed circuits or semiconductor circuit elements, e.g. credit or identity cards also with resonating or responding marks without active components
- G06K19/07—Record carriers with conductive marks, printed circuits or semiconductor circuit elements, e.g. credit or identity cards also with resonating or responding marks without active components with integrated circuit chips
- G06K19/077—Constructional details, e.g. mounting of circuits in the carrier
- G06K19/0772—Physical layout of the record carrier
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06K—GRAPHICAL DATA READING; PRESENTATION OF DATA; RECORD CARRIERS; HANDLING RECORD CARRIERS
- G06K7/00—Methods or arrangements for sensing record carriers, e.g. for reading patterns
- G06K7/10—Methods or arrangements for sensing record carriers, e.g. for reading patterns by electromagnetic radiation, e.g. optical sensing; by corpuscular radiation
- G06K7/10009—Methods or arrangements for sensing record carriers, e.g. for reading patterns by electromagnetic radiation, e.g. optical sensing; by corpuscular radiation sensing by radiation using wavelengths larger than 0.1 mm, e.g. radio-waves or microwaves
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
- G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
- G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
- G16H20/13—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients delivered from dispensers
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H40/00—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
- G16H40/60—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices
- G16H40/63—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for local operation
- H—ELECTRICITY
- H04—ELECTRIC COMMUNICATION TECHNIQUE
- H04B—TRANSMISSION
- H04B1/00—Details of transmission systems, not covered by a single one of groups H04B3/00 - H04B13/00; Details of transmission systems not characterised by the medium used for transmission
- H04B1/59—Responders; Transponders

Landscapes

Engineering & Computer Science (AREA)
Health & Medical Sciences (AREA)
Microelectronics & Electronic Packaging (AREA)
Computer Hardware Design (AREA)
General Health & Medical Sciences (AREA)
Physics & Mathematics (AREA)
Medical Informatics (AREA)
General Physics & Mathematics (AREA)
Primary Health Care (AREA)
Public Health (AREA)
Theoretical Computer Science (AREA)
Epidemiology (AREA)
Biomedical Technology (AREA)
Medicinal Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical & Material Sciences (AREA)
General Business, Economics & Management (AREA)
Business, Economics & Management (AREA)
Computer Networks & Wireless Communication (AREA)
Toxicology (AREA)
Signal Processing (AREA)
Electromagnetism (AREA)
Artificial Intelligence (AREA)
Computer Vision & Pattern Recognition (AREA)
Medical Preparation Storing Or Oral Administration Devices (AREA)
Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
Medical Treatment And Welfare Office Work (AREA)
Measuring And Recording Apparatus For Diagnosis (AREA)

CA3211663A 2015-10-13 2015-10-13 Systeme electronique de surveillance de la conformite de la medication et methodes associees Pending CA3211663A1 (fr)

Priority Applications (1)

Application Number	Priority Date	Filing Date	Title
CA3211663A CA3211663A1 (fr)	2015-10-13	2015-10-13	Systeme electronique de surveillance de la conformite de la medication et methodes associees

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
CA2909033A CA2909033C (fr)	2015-10-13	2015-10-13	Systeme electronique de surveillance de la conformite de la medication et methodes associees
CA3211663A CA3211663A1 (fr)	2015-10-13	2015-10-13	Systeme electronique de surveillance de la conformite de la medication et methodes associees

Related Parent Applications (1)

Application Number	Title	Priority Date	Filing Date
CA2909033A Division CA2909033C (fr)	2015-10-13	2015-10-13	Systeme electronique de surveillance de la conformite de la medication et methodes associees

Publications (1)

Publication Number	Publication Date
CA3211663A1 true CA3211663A1 (fr)	2017-04-13

Family

ID=58534654

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
CA2909033A Active CA2909033C (fr)	2015-10-13	2015-10-13	Systeme electronique de surveillance de la conformite de la medication et methodes associees
CA3211663A Pending CA3211663A1 (fr)	2015-10-13	2015-10-13	Systeme electronique de surveillance de la conformite de la medication et methodes associees

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
CA2909033A Active CA2909033C (fr)	2015-10-13	2015-10-13	Systeme electronique de surveillance de la conformite de la medication et methodes associees

Country Status (1)

Country	Link
CA (2)	CA2909033C (fr)

2015
- 2015-10-13 CA CA2909033A patent/CA2909033C/fr active Active
- 2015-10-13 CA CA3211663A patent/CA3211663A1/fr active Pending

Also Published As

Publication number	Publication date
CA2909033A1 (fr)	2017-04-13
CA2909033C (fr)	2023-09-26

Legal Events

Date	Code	Title	Description
2024-01-10	EEER	Examination request	Effective date: 20231208

Publication	Publication Date	Title
US10765360B2 (en)	2020-09-08	Electronic medication compliance monitoring system and associated methods
US10292642B2 (en)	2019-05-21	Electronic medication compliance monitoring system and associated methods
US20240212841A1 (en)	2024-06-27	Electronic compliance system and associated methods
US20140309505A1 (en)	2014-10-16	Electronic medication compliance monitoring system and associated methods
US11612321B2 (en)	2023-03-28	Transbody communication systems employing communication channels
JP5706504B2 (ja)	2015-04-22	摂取可能な事象マーカシステム
US8115618B2 (en)	2012-02-14	RFID antenna for in-body device
US9161707B2 (en)	2015-10-20	Communication system incorporated in an ingestible product
US20160380708A1 (en)	2016-12-29	Systems and methods for resolving ingestible event marker (iem) contention
WO2013078405A1 (fr)	2013-05-30	Système de communication intégré dans un récipient
CA2909033C (fr)	2023-09-26	Systeme electronique de surveillance de la conformite de la medication et methodes associees
AU2015243053A1 (en)	2017-05-04	Electronic medication compliance monitoring system and associated methods